Cargando…
Recent Clinical and Preclinical Advances in External Stimuli-Responsive Therapies for Head and Neck Squamous Cell Carcinoma
Head and neck squamous cell carcinoma (HNSCC) has long been one of the most prevalent cancers worldwide; even though treatments such as surgery, chemotherapy, radiotherapy and immunotherapy have been proven to benefit the patients and prolong their survival time, the overall five-year survival rate...
Autores principales: | Jiang, Zheng, Yang, Xin, Ainiwaer, Mailudan, Chen, Fei, Liu, Jun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9821160/ https://www.ncbi.nlm.nih.gov/pubmed/36614974 http://dx.doi.org/10.3390/jcm12010173 |
Ejemplares similares
-
Versatility and outcomes of lateral arm free flap in head and neck reconstruction: a retrospective case series study of our experiences and innovations
por: Ainiwaer, Mailudan, et al.
Publicado: (2023) -
Preclinical models in head and neck squamous cell carcinoma
por: Chaves, Patricia, et al.
Publicado: (2023) -
Recent Advances in Biomarkers and Potential Targeted Therapies in Head and Neck Squamous Cell Carcinoma
por: Yavrouian, Eric J., et al.
Publicado: (2012) -
Immunomodulatory Therapy in Head and Neck Squamous Cell Carcinoma: Recent Advances and Clinical Prospects
por: Khadela, Avinash, et al.
Publicado: (2023) -
Recent Advances in Immunotherapy for Patients with Head and Neck Cutaneous Squamous Cell Carcinoma
por: Khorasanchi, Adam, et al.
Publicado: (2022)